Selenomethionine in the inhibition of a transplantable murine lymphoma: reflection on hepatic drug metabolizing enzymes.

@article{Rana1996SelenomethionineIT,
  title={Selenomethionine in the inhibition of a transplantable murine lymphoma: reflection on hepatic drug metabolizing enzymes.},
  author={Mahendra Pratap Rana and Sujit Kumar Sardar and Mary Chatterjee},
  journal={Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine},
  year={1996},
  volume={17 2},
  pages={
          102-9
        }
}
This study attempts to determine whether selenomethionine treatment can improve the survival time of mice inoculated with Dalton's lymphoma (DL) and thereby to identify phase/phases of the neoplastic processes at which selenium exerts its maximal action as an anticancer agent. Accordingly, a maximum of 30.76 and 143% increase in survival was brought about by treatment of selenomethionine prior to lymphoma transplantation, in comparison to mice receiving selenomethione supplementation… CONTINUE READING